The U.S. National Institutes of Health (NIH) and the U.S. Department of Health and Human Services (HHS) have recently announced what they are calling a “next-generation, universal vaccine platform.” The project, branded Generation Gold Standard, is being promoted as a major leap forward in vaccine science and safety assessment. Public figures, including RFK Jr., have spoken about it as if it were the solution to the failures of the COVID-19 vaccines — the dawn of a new, “safe and effective” vaccine era.
Before accepting these claims, it is worth examining them from the standpoint of actual science — specifically chemistry — to assess the validity of the approach and the likelihood of success (more like its failure).
According to HHS, this new platform will use a beta-propiolactone (BPL)-inactivated, whole-virus system. NIH Director Jay Bhattacharya has called it a “paradigm shift,” claiming it will extend vaccine protection beyond strain-specific limits and prepare the public for future flu viral threats, using traditional vaccine technology brought “into the 21st century.”
Yet even within the vaccine field, some experts have expressed surprise. Gregory Poland, a long-time vaccine researcher, points out that this is not new technology at all but a return to methods used in the 1940s, 50s, and 60s. In his view, this is going backwards, not forwards.
The so-called innovation here rests on the use of beta-propiolactone to inactivate viruses. Chemically, BPL is a small and highly reactive molecule, known for its strong sterilizing and sporicidal properties. It is a colorless liquid with a slightly sweet odor, highly soluble in both water and organic solvents, and is classified as carcinogenic — a fact that has severely limited its commercial use.
Historically, vaccine developers relied more on formaldehyde for chemical inactivation, and even earlier, they used physical methods such as heat. The decision to return to a chemical agent, especially one with a known carcinogenic profile, raises serious safety questions that cannot be brushed aside by marketing language.
What also needs to be emphasized is that the concept itself is far from new. The earliest vaccines were developed by growing a virus and then deactivating it so it could be introduced into the body without causing disease. That was the foundation of the whole vaccine idea more than half a century ago. Calling this “next-generation” technology is essentially rebranding an old idea, with the only modern twist being the choice of a different chemical for inactivation.
Even more fundamental is the issue of what exactly they are planning to inactivate. If the existence of the virus in question has not been scientifically demonstrated through proper isolation and characterization, then there is nothing real to inactivate in the first place. This makes the entire claim nothing more than a story constructed to maintain the appearance of scientific progress.
Another revealing point is the sudden and almost complete absence of any reference to mRNA technology in this announcement — the Nobel Prize-winning technology once hailed as the greatest vaccine innovation of our time. Just a few years ago, mRNA was marketed as the miraculous platform that would revolutionize public health. Today, it appears to have been quietly set aside. The pivot back to mid-20th-century methods strongly suggests that even within the establishment, confidence in mRNA’s long-term viability is fading.
From a chemical science perspective, Generation Gold Standard is not a paradigm shift but a return to old methods dressed up in new language. The safety concerns surrounding BPL are significant, and the platform’s entire foundation relies on the assumption that a virus exists to be inactivated, while still working with the same junk/gunk virus-isolate considered as the virus. Without conclusive evidence for that, i.e., the availability of an isolated and purified virus sample, the project is nothing more than a marketing exercise. Far from representing the future of vaccination, it may actually be a step back into its past — and also ignoring the lack of safety aspect of that past.
On top of that, the government (HHS) has thrown $500 million at this so-called “next-generation” vaccine platform — a move that makes no sense by any genuine scientific standard. They are funding a half-billion-dollar project for a supposed treatment for the flu — which, by any reasonable measure, is simply the body’s normal adjustment hiccup, known to resolve with rest, warm fluids, and perhaps some vitamin C. As for COVID-19, by any honest standard, it does not exist — because the virus itself has never been proven to exist.
Moreover, allocating $500 million for a project (clinical studies) is entirely unwarranted. It suggests that someone unfamiliar with science beyond the clinical veneer is making the estimate. Such an enormous sum for conducting a relatively simple test — labeled as a “clinical trial” — should be far, far less than the amount proposed, unless there is some other intent behind extracting such a large sum of money.
It is doubtful that any other country’s leadership or its associated agencies would squander such a vast sum of money on what appears to be a treatment trial for questionable or even fabricated illnesses. More likely, they would be laughing at such a proposal, recognizing the steady deterioration of modern scientific capability.
In short, there’s nothing new here, at least scientifically: the approach is old, previously tested, and proven to fail. There is no proper viral isolation to confirm its existence, no rigorous testing against real viruses, no patient trials, and no credible testing (valid tests) to monitor outcomes from clinical trials.
It’s an illusion — a carefully staged performance by medical scientists selling a false brand of “science.” In reality, it’s a calculated scheme to keep the vaccine program alive, fool political leaders, and silence growing public calls to shut it down. More importantly, it’s designed to protect fake, fraudulent “medical science” by cloaking it in the appearance of real science, even after the COVID-19 experience has exposed it for what it is – a fraud.
NIH announcement about the universal vaccine (link).
Trump administration’s universal flu vaccine project puzzles scientists (link)
β-Propiolactone (BPL, link)
HHS, NIH Launch $500 Million Project to Develop Universal Vaccines to Protect Against ‘Pandemic-Prone’ Viruses (link)
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine (link)